Innovation & Research

Last Publications

Delafloxacin: Activity against Fastidious Organisms Tested by EUCAST vs CLSI Methodology

CD205-Shuttle Study: a first in human trial of Men1309/OBT076 an ADC targeting CD205 in solid tumor and NHL

Translational model-based approach to the dose-range selection of an antibody-drug conjugate entering Phase I.

The role of MEN1611, a class I PI3-kinase (PI3K) inhibitor, in reprogramming the pro-tumoral inflammatory environment.

MEN1611, a novel a-selective PI3K inhibitor in solid tumors

Search Menarini in the world

v

Etiam commodo dui eget wisi. Donec iaculis gravida nulla. Donec quis nibh at felis congue commodo. Etiam bibendum elit eget erat.

Partnering

Drug development is a challenging process, and success relies on the integration of innovative scientific discoveries with the necessary capabilities and resources to transform them into effective healthcare solutions.

Read More